Global Exocrine Pancreatic Insufficiency Diagnostics Market US$ 2.5 Billion by 2021

Global Exocrine Pancreatic Insufficiency Diagnostics Market US$ 2.5 Billion by 2021

Exocrine pancreatic insufficiency (EPI) is a condition characterized by deficiency of the exocrine pancreatic enzymes. This results in the inability to digest food properly or maldigestion. These enzymes consist of lipases, proteases and amylases. A complete laboratory evaluation including pancreatic function testing is required to diagnose EPI and to determine the extent of the malabsorption.

Exocrine Pancreatic Insufficiency Diagnostics Market 2017-2021 report estimates the global exocrine pancreatic insufficiency diagnostics market to reach nearly US$ 2.3 Billion in 2020, at a CAGR of 8.9% from 2017 to 2021 – iHealthcareAnalyst, Inc.

Visit the Exocrine Pancreatic Insufficiency Diagnostics Market 2017-2021 report https://www.ihealthcareanalyst.com/report/exocrine-pancreatic-insufficiency-diagnostics-market/

The global exocrine pancreatic insufficiency diagnostics market segmentation is based on diagnostic test types (blood tests, endoscopic ultra-sonography, magnetic resonance imaging, CT scanning). The global exocrine pancreatic insufficiency diagnostics market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).

The global exocrine pancreatic insufficiency diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Test Type
1.1 Blood Tests
1.2 Endoscopic Ultra-Sonography (EUS)
1.3 Magnetic Resonance Imaging (MRI)
1.4 CT Scanning

2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World

3. Company Profiles
3.1 Abbvie Inc.
3.2 Allergan plc.
3.3 Anthera Pharmaceuticals Inc.
3.4 AzurRx BioPharma, Inc.
3.4 Cilian AG
3.6 Digestive Care,Inc.
3.7 Nordmark Arzneimittel GmbH & Co. KG
3.8 Janssen Pharmaceuticals Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2017-11-05T09:56:10+00:00 Categories: Press Releases|